|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.526 EUR | +2.32% |
|
-3.71% | -25.30% |
| Apr. 11 | Valneva: Deep Track Biotechnology Master holds less than 5% of the capital | CF |
| Mar. 26 | Valneva Kicks Off Early-stage Trial for Zika Vaccine Candidate | MT |
EMA: EMA PUBLISHED UPDATED INFORMATION ON COVID-19 VACCINE VALNEVA, WITH AN INCREASE IN ITS APPROVED SHELF LIFE: 05/12/2022
| 1st Jan change | Capi. | |
|---|---|---|
| -25.30% | 512M | |
| +1.12% | 42.59B | |
| +6.77% | 40.65B | |
| +47.41% | 40.57B | |
| -11.96% | 26.77B | |
| +6.01% | 24.81B | |
| -24.92% | 18.17B | |
| -3.63% | 11.7B | |
| +27.16% | 12.05B | |
| +7.30% | 11.1B |
VALNEVA 
